96 related articles for article (PubMed ID: 27644641)
41. Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer.
Zhou F; Chen E; You D; Song Y; Sun Z; Yue L
APMIS; 2016 Dec; 124(12):1046-1053. PubMed ID: 27714846
[TBL] [Abstract][Full Text] [Related]
42. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
43. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer.
Lv B; Song C; Wu L; Zhang Q; Hou D; Chen P; Yu S; Wang Z; Chu Y; Zhang J; Yang D; Liu J
Oncotarget; 2015; 6(12):9794-806. PubMed ID: 25909166
[TBL] [Abstract][Full Text] [Related]
44. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of heat shock proteins in normal and failing human hearts.
Knowlton AA; Kapadia S; Torre-Amione G; Durand JB; Bies R; Young J; Mann DL
J Mol Cell Cardiol; 1998 Apr; 30(4):811-8. PubMed ID: 9602430
[TBL] [Abstract][Full Text] [Related]
46. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
47. Colonic mucosal expression of heat-shock proteins may have a potential prognostic value in ulcerative colitis.
Abou El Azm AR; Yousef M; Kobtan A; Awad A; Elkassas G; Elfert A
Arab J Gastroenterol; 2015 Mar; 16(1):20-4. PubMed ID: 25797489
[TBL] [Abstract][Full Text] [Related]
48. [Expression of heat shock proteins in salivary gland tumors. Immunohistochemical study of HSP27, HSP70, HSP90, and HSP110: apropos of 50 cases].
Vanmuylder N; Evrard L; Daelemans P; Van Reck J; Dourov N
Ann Pathol; 2000 May; 20(3):190-5. PubMed ID: 10891711
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma.
Söderström HK; Kauppi JT; Oksala N; Paavonen T; Krogerus L; Räsänen J; Rantanen T
World J Clin Cases; 2019 Feb; 7(3):260-269. PubMed ID: 30746368
[TBL] [Abstract][Full Text] [Related]
50. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
51. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
[TBL] [Abstract][Full Text] [Related]
52. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
Dolasik I; Birtas Atesoglu E; Tarkun P; Mehtap O; Keski H; Dogru A; Hacihanefioglu A
Platelets; 2015; 26(3):220-3. PubMed ID: 24749912
[TBL] [Abstract][Full Text] [Related]
53. Heat shock proteins as biomarkers of lung cancer.
Mittal S; Rajala MS
Cancer Biol Ther; 2020 Jun; 21(6):477-485. PubMed ID: 32228356
[TBL] [Abstract][Full Text] [Related]
54. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.
Ciocca DR; Calderwood SK
Cell Stress Chaperones; 2005; 10(2):86-103. PubMed ID: 16038406
[TBL] [Abstract][Full Text] [Related]
55. Mitochondrial Proteomics Approach Reveals Voltage-Dependent Anion Channel 1 (VDAC1) as a Potential Biomarker of Gastric Cancer.
Gao W; Xua J; Wang F; Zhang L; Peng R; Zhu Y; Tang Q; Wu J
Cell Physiol Biochem; 2015; 37(6):2339-54. PubMed ID: 26646027
[TBL] [Abstract][Full Text] [Related]
56. The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer.
Hoter A; Rizk S; Naim HY
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426412
[TBL] [Abstract][Full Text] [Related]
57. Heat Shock Proteins in Cancer Immunotherapy.
Das JK; Xiong X; Ren X; Yang JM; Song J
J Oncol; 2019; 2019():3267207. PubMed ID: 31885572
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive Pan-Cancer Analysis of Heat Shock Protein 110, 90, 70, and 60 Families.
Yan LR; Shen SX; Wang A; Ding HX; Liu YN; Yuan Y; Xu Q
Front Mol Biosci; 2021; 8():726244. PubMed ID: 34712697
[No Abstract] [Full Text] [Related]
59. Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.
Babi A; Menlibayeva K; Bex T; Doskaliev A; Akshulakov S; Shevtsov M
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358853
[TBL] [Abstract][Full Text] [Related]
60. Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
Lee MS; Lee J; Lee S; Yoo SM; Kim JH; Kim WT; Kim WJ; Park J
Oncotarget; 2018 Jan; 9(8):7961-7974. PubMed ID: 29487706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
